Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.
- NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_assertion wasGeneratedBy ECO_0000203 NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.
- NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_assertion wasDerivedFrom befree-20150227 NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.
- NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_assertion SIO_000772 17631045 NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.
- NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_assertion evidence source_evidence_literature NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.
- NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_assertion description "[An HIV-1/hepatitis C virus (HCV) co-infected patient with haemophilia received a 48-week course of pegylated interferon-alpha-2b and ribavirin therapy for genotype 5a HCV infection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477336.RA_TfXd0E0oOEcC3dN7sp-TZp6lRpAuSRdbD2fqCjAe-8130_provenance.